Sonography-Guided Volumetric Rejuvenation on Dorsal Hands

August 28, 2023 updated by: Yi-Teng Hung, Chang Gung Memorial Hospital

Sonography-Guided Volumetric Rejuvenation on Dorsal Hands: A Split-Hand Randomized Controlled Trial

The goal of this randomized controlled study is to guide volumetric rejuvenation on dorsal hands with the maximal aesthetic appearance. The main questions it aims to answer are:

  • Which fatty layer(s) is/are the most suitable for filler injection?
  • Is it feasible to make precise filler injections with sonography guidance? Participants will receive sonography-guided injection on the one hand and another with blinded injection.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

In our previous study, volumetric fat loss was noted in the 3 fatty laminae of dorsal hands during aging; the dorsal intermediate lamina (DIL) showed the greatest progressive fat loss after the age of 30. Volumetric rejuvenation of the 3 laminae may result in the most aesthetic appearance, especially in women. It is necessary to develop precise rejuvenation therapies according to the aging process of the dorsum of the hands that will yield the most aesthetic appearance.

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Diagnosis of aging changes on the dorsal hands
  • Aged ≥18 years

Exclusion Criteria:

  • History of severe hand dermatitis
  • History of rheumatic arthritis
  • History of major hand trauma
  • History of limb edema
  • History of recent significant weight changes
  • History of previous filler injection to the dorsal hands
  • History of intravenous catheter insertion and hemodialysis via the forearms or hands

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Sonography-guided hand
One hand of the participant will be treated with sonography-guided filler injection in random
Volumetric Rejuvenation with FDA-approved fillers on the skin of the dorsal hands
No Intervention: Blinded injected hand
One hand of the participant will be treated with filler injection by physician's experience without sonography-guidance in random

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Aesthetic improvement
Time Frame: Day 0, 30, 180 follow up
5-point global aesthetic improvement scales scoring (Min:1; Max:5)
Day 0, 30, 180 follow up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Thickness of the fatty laer
Time Frame: Day 0, 30, 180 follow up
Thickness of the dorsal superficial lamina (DSL) and dorsal intermediate lamina (DIL)
Day 0, 30, 180 follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yi-Teng Hung, MD, Chang Gung memorial hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 15, 2023

Primary Completion (Estimated)

December 31, 2024

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

April 6, 2023

First Submitted That Met QC Criteria

April 6, 2023

First Posted (Actual)

April 19, 2023

Study Record Updates

Last Update Posted (Actual)

August 30, 2023

Last Update Submitted That Met QC Criteria

August 28, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 202101547B0

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ultrasound

Clinical Trials on Volumetric rejuvenation

3
Subscribe